Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AngioDynamics Announces Conference Call for Second Quarter FY08 Financial Results.


QUEENSBURY, N.Y. -- AngioDynamics (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:ANGO ANGO Algemene Nederlandse Gehandicapten Organisatie (Dutch: Equal Opportunities for Persons with Disabilities) ), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease Peripheral Vascular Disease Definition

Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms.
, announced today that it plans to report its second fiscal quarter financial results on Thursday, January 3, 2008, after the close of the financial markets.

Eamonn P. Hobbs, president and chief executive officer, and Joseph Gersuk, executive vice president and CFO See Chief Financial Officer. , will host an investment community conference call beginning at 4:30 p.m. Eastern time on January 3rd to discuss these results and to answer questions.

To participate in the live call by telephone, please dial (800) 218-0204 from the U.S., or for international callers, please dial (303) 262-2142.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 section of AngioDynamics' website at http://investor.angiodynamics.com. To listen to the live call, please go to the website 15 minutes prior to its start to register, download, and install the necessary audio software.

A replay will be available on the website. A telephone replay will be available from 7:30 p.m. Eastern time on January 3, 2008 through 11:59 p.m. Eastern time on January 11 by dialing (800) 405-2236 (domestic) or (303) 590-3000 (international) and entering the passcode: 11104157#.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic thrombolytic /throm·bo·lyt·ic/ (throm?bo-lit´ik) dissolving or splitting up a thrombus, or an agent that so acts.

thrombolytic

1. dissolving or splitting up a thrombus.

2. an agent that dissolves or splits up a thrombus.
 products, embolization embolization /em·bo·li·za·tion/ (em?bo-li-za´shun)
1. the process or condition of becoming an embolus.

2. therapeutic introduction of a substance into a vessel in order to occlude it.
 products and venous products.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 20, 2007
Words:286
Previous Article:Rick's Cabaret International, Inc. Reports Record Net Income for Fiscal 2007 with 74.3 Percent Increase from Previous Year; Net Earnings Are 54 Cents...
Next Article:Home Diagnostics, Inc. and Roche Reach Settlement Agreement.



Related Articles
AngioDynamics Net Income Up 60% on 30% Increase to Record Net Sales in Second Quarter of Fiscal 2006; Conference Call to Begin Today at 4:30 pm ET.
AngioDynamics Reports Record Second Quarter Sales and Net Income.
AngioDynamics Reports Fourth Quarter and Fiscal 2007 Results.
AngioDynamics Reports 70% Second Quarter Sales Growth.
AngioDynamics reports 70% jump in Q2 net sales.
HP Reports First Quarter 2008 Results.
Volume 8, Number 23 Oil Market and Budget Developments.
Volume 8, Number 23 Oil Market and Budget Developments.
Volume 8, Number 23 Oil Market and Budget Developments.
HP Reports Third Quarter 2008 Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles